Lilly will gain worldwide rights for the development and commercialisation of DACRA molecules to treat obesity. Credit: New Africa/Shutterstock. Nordic Bioscience subsidiary KeyBioscience has ...

Switzerland-based KeyBioscience and US pharma major Eli Lilly have agreed to extend their collaboration on the development of dual amylin calcitonin receptor agonists (DACRA), a new class of potential ...

The high court heard arguments Thursday morning on Attorney General Dana Nessel’s effort to investigate and potentially sue the drug company Eli Lilly on the grounds that its insulin pricing ...

Eli Lilly And Co. (NYSE:LLY) is ramping up its legal campaign against the compounding companies temporarily allowed to make and sell copycat versions of its blockbuster drugs for weight loss until a U ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other the Stock That Will Make You Rich in 5-10 Years. The US economy grew by 3% in the ...

Infrastructure specialist Renew has sold its specialist building arm Walter Lilly. Walter Lilly has been in business since 1924 working on building jobs across London and the South East.

Eli Lilly has finally made enough supply of its popular medicine tirzepatide to meet soaring demand, which should help the company widen its share of the booming weight-loss drug market.

The Food and Drug Administration said Wednesday that the shortage of Lilly’s Zepbound and Mounjaro is resolved. The agency added that there are “legal restrictions on making copies of FDA ...

The health regulator said it confirmed with Lilly that the current supply and manufacturing capacity could meet the present and projected national demand for the drug. Originally developed for ...

Matthew Lewis, a Washington Post photographer who won the Pulitzer Prize for his portfolio of Washington-area personalities and ways of life and who became the newspaper’s first Black assistant ...

BioAge Labs is working on therapies for obesity as well as aging. It has plenty of cash, and it's collaborating with Eli Lilly and Novo Nordisk. Its pipeline programs aren't as early-stage as ...